Predicting functional decline and survival in amyotrophic lateral sclerosis

Abstract

Using combinations of small numbers of variables it was possible to predict classes of functional decline and survival across the 1-2 year timeframe available in PRO-ACT. These findings may have utility for design of future ALS clinical trials.